Levasseur, L M <br/><br/>
Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1997 
 - 495-505 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s002800050693  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cell Division--drug effects<br/>Cisplatin--administration & dosage<br/>Colonic Neoplasms--pathology<br/>Drug Resistance, Neoplasm<br/>Female<br/>Head and Neck Neoplasms--pathology<br/>Humans<br/>Ovarian Neoplasms--pathology<br/>Paclitaxel--administration & dosage<br/>Tumor Cells, Cultured